Major HRT study halted over breast cancer fears

DOCTORS have halted another major hormone replacement therapy (HRT) study after early findings showed women were facing an “unacceptably high risk” of breast cancer, it was revealed yesterday.

The Swedish trial was to assess the effect of HRT on women with a previous history of the disease.

It was stopped three years early when results showed HRT significantly increased the chances of recurring breast cancer or the appearance of a new tumour.